BRCA1 and cancer: We demonstrate that oncogenic β-catenin activation acts synergistically with BRCA1/2 deficiency in eliminating cancer cells and we identify the underlying mechanism as transcriptional deregulation of specific gene targets, with genotoxic consequences.